Independent Director's 2025 Annual Work Report
As an independent director of Beijing Saisheng Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company"), I, Dai Yunping, have strictly adhered to the provisions and requirements of the Company Law, Securities Law, Management Measures for Independent Directors of Listed Companies, and other relevant laws, regulations, normative documents, as well as the Articles of Association and the Independent Director Work System during my tenure. With a commitment to all shareholders, I have diligently and faithfully fulfilled my responsibilities as an independent director, providing objective, prudent, and fair independent opinions on significant matters of the Company, actively safeguarding the interests of the Company and the legal rights of shareholders, especially minority shareholders, and effectively playing the role of an independent director and a member of the board's specialized committees. The following is my performance report for the year 2025:
I. Basic Information of the Independent Director
(1) Work Experience, Professional Background, and Concurrent Positions
Dai Yunping, male, born in January 1963, Chinese nationality, no permanent residency abroad, graduated from Beijing Normal University with a major in biology, associate degree, visiting scholar at the University of Connecticut, USA. Since 1982, I have served as a laboratory technician in microbiology at Beijing Agricultural University, a researcher at the National Key Laboratory of Agricultural Biotechnology at China Agricultural University, a research expert at the University of Connecticut, and a senior laboratory technician at the College of Biology at China Agricultural University. During my career, I have published 11 SCI papers as the first author or corresponding author, 56 SCI papers as a co-author, and obtained 19 patents. I have been serving as an independent director of the Company since January 26, 2024.
(2) Independence Statement
During my tenure as an independent director, I have not held any position in the Company other than that of an independent director, nor have I held any position in the Company's major shareholder companies. There are no relationships with the Company or major shareholders that would hinder my ability to make independent and objective judgments, and there are no circumstances affecting the independence of the independent director. I meet the relevant requirements regarding the independence of independent directors as stipulated in the Management Measures for Independent Directors of Listed Companies, the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange, and the Articles of Association and Independent Director Work System of the Company.
II. Annual Performance Overview of the Independent Director
(1) Attendance at Board and Shareholder Meetings
In 2025, the Company held a total of 7 board meetings, and I attended all of them in person without delegating my voting rights to others. I carefully reviewed all proposals submitted to the board and maintained sufficient communication with the Company's management, actively participating in discussions and providing reasonable suggestions, exercising my voting rights with a cautious and responsible attitude. I believe that the convening and holding of the board meetings complied with legal procedures, and all significant matters underwent the relevant approval processes, being legal and effective, without harming the interests of the Company and all shareholders. Therefore, I voted in favor of all proposals and other matters presented at the 2025 board meetings, with no objections or abstentions. The Company held a total of 3 shareholder meetings in 2025, and I attended all of them in person.